this PDF file
... Each item was rated on a five-point scale ranging from “strongly disagree” to “strongly agree” (MacLean et al., 2011). The results of this study showed that participants who had a mystical experience during a psilocybin session had remained significantly more open compared to the control group more ...
... Each item was rated on a five-point scale ranging from “strongly disagree” to “strongly agree” (MacLean et al., 2011). The results of this study showed that participants who had a mystical experience during a psilocybin session had remained significantly more open compared to the control group more ...
Class Update: Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
... reported higher incidence of nonfatal stroke with canagliflozin, another SGLT2 inhibitor, compared to controls (HR 1.46; 95% CI 0.83 to 2.58).4 Canagliflozin has also been associated with increased rates of bone fractures. The long‐term effect of SGLT2 inhibitors on bone density is still unknown.2 ...
... reported higher incidence of nonfatal stroke with canagliflozin, another SGLT2 inhibitor, compared to controls (HR 1.46; 95% CI 0.83 to 2.58).4 Canagliflozin has also been associated with increased rates of bone fractures. The long‐term effect of SGLT2 inhibitors on bone density is still unknown.2 ...
The Psychedelic Renaissance: Horizons, the Fifth Annual Conference on Psychedelic Research
... Each item was rated on a five-point scale ranging from “strongly disagree” to “strongly agree” (MacLean et al., 2011). The results of this study showed that participants who had a mystical experience during a psilocybin session had remained significantly more open compared to the control group more ...
... Each item was rated on a five-point scale ranging from “strongly disagree” to “strongly agree” (MacLean et al., 2011). The results of this study showed that participants who had a mystical experience during a psilocybin session had remained significantly more open compared to the control group more ...
Ref: SAMHSA - Temple University Sites
... Patients typically must go to appointments daily Potential for home use (7-30 days) Ref: SAMHSA ...
... Patients typically must go to appointments daily Potential for home use (7-30 days) Ref: SAMHSA ...
Patterns of antibiotic treatment failure in pediatric community
... • Pediatric patients are almost two times more likely to receive a macrolide antibiotic compared to a beta-lactam drug when initially treated for CABP. The specific drug used within each class can be found in Table 1. • Consistent with guidelines, Fluoroquinolones and tetracyclines make up a smaller ...
... • Pediatric patients are almost two times more likely to receive a macrolide antibiotic compared to a beta-lactam drug when initially treated for CABP. The specific drug used within each class can be found in Table 1. • Consistent with guidelines, Fluoroquinolones and tetracyclines make up a smaller ...
35 Generic Name Dicyclomine IUPAC Name 2
... Action is achieved via a dual mechanism: (1) a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and (2) a direct effect upon smooth muscle (musculotropic). ...
... Action is achieved via a dual mechanism: (1) a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and (2) a direct effect upon smooth muscle (musculotropic). ...
View Document
... safely. This class of medicine is in the list of drugs included in regulations under 5a of the Road Traffic Act 1988. When prescribing this medicine, patients should be ...
... safely. This class of medicine is in the list of drugs included in regulations under 5a of the Road Traffic Act 1988. When prescribing this medicine, patients should be ...
Lumacaftor-Ivacaftor - Vertex Pharmaceuticals
... The following adverse reactions are discussed in greater detail in other sections of the label: • Use in Patients with Advanced Liver Disease [see Warnings and Precautions (5.1)] • Liver-related Events [see Warnings and Precautions (5.2)] • Respiratory Events [see Warnings and Precautions (5.3)] • E ...
... The following adverse reactions are discussed in greater detail in other sections of the label: • Use in Patients with Advanced Liver Disease [see Warnings and Precautions (5.1)] • Liver-related Events [see Warnings and Precautions (5.2)] • Respiratory Events [see Warnings and Precautions (5.3)] • E ...
Advanced L-Theanine Calm-Plex - ProHealth`s Advanced Medical
... alpha-waves in the brain. After 60 minutes of Gaba administration it was shown that healthy subjects had an increase in the relaxing alpha waves and a decrease in beta brain waves. In addition, these same subjects were tested under a stressful situation after ingesting Gaba and found that the levels ...
... alpha-waves in the brain. After 60 minutes of Gaba administration it was shown that healthy subjects had an increase in the relaxing alpha waves and a decrease in beta brain waves. In addition, these same subjects were tested under a stressful situation after ingesting Gaba and found that the levels ...
Eltor (pseudoephedrine hydrochloride)
... In a study6 using maximal nasal inspiratory flow rate as a test of nasal decongestion, ten patients with vasomotor rhinitis were given 60 mg oral pseudoephedrine. A statistically significant increase in nasal air flow was observed in comparison to an oral lactose placebo. The objective improvement w ...
... In a study6 using maximal nasal inspiratory flow rate as a test of nasal decongestion, ten patients with vasomotor rhinitis were given 60 mg oral pseudoephedrine. A statistically significant increase in nasal air flow was observed in comparison to an oral lactose placebo. The objective improvement w ...
pdf, 282 KB - NHS Basildon and Brentwood CCG
... prescriptions for sildenafil no longer require the prescriber to annotate them with the letters “SLS”. In June 2013, the UK patent protection for Viagra expired. Following this, the price of generic preparations of sildenafil dropped by around 95% of the price of branded Viagra, from £21.27 to £1.12 ...
... prescriptions for sildenafil no longer require the prescriber to annotate them with the letters “SLS”. In June 2013, the UK patent protection for Viagra expired. Following this, the price of generic preparations of sildenafil dropped by around 95% of the price of branded Viagra, from £21.27 to £1.12 ...
- ISpatula
... linked to twice the risk for miscarriage, according to the results of a nested case-control study reported online September 6 in the Canadian Medical Association Journal. Of the 4705 patients with spontaneous abortion, 352 (7.5%) had NSAID exposure, as did 1213 (2.6%) of 47,050 control participants. ...
... linked to twice the risk for miscarriage, according to the results of a nested case-control study reported online September 6 in the Canadian Medical Association Journal. Of the 4705 patients with spontaneous abortion, 352 (7.5%) had NSAID exposure, as did 1213 (2.6%) of 47,050 control participants. ...
OTC analgesics
... linked to twice the risk for miscarriage, according to the results of a nested case-control study reported online September 6 in the Canadian Medical Association Journal. Of the 4705 patients with spontaneous abortion, 352 (7.5%) had NSAID exposure, as did 1213 (2.6%) of 47,050 control participants. ...
... linked to twice the risk for miscarriage, according to the results of a nested case-control study reported online September 6 in the Canadian Medical Association Journal. Of the 4705 patients with spontaneous abortion, 352 (7.5%) had NSAID exposure, as did 1213 (2.6%) of 47,050 control participants. ...
Clinical trials
... its safety, determine a safe dosage range. In Phase II trials, the study drug or treatment is given to a selected group of patients (100 – 300) to see if it is effective and to further evaluate its safety. In Phase III trials, the study drug or treatment is given to a large group of patients ( 1000 ...
... its safety, determine a safe dosage range. In Phase II trials, the study drug or treatment is given to a selected group of patients (100 – 300) to see if it is effective and to further evaluate its safety. In Phase III trials, the study drug or treatment is given to a large group of patients ( 1000 ...
Physician Views: What Opportunity for Gilead Sciences' Hepatitis C Therapy
... In genotype 1 patients - which account for the vast majority of the US hepatitis C population - the outlook is more complicated. Treatment with sofosbuvir will still require co-administration with ribavirin and interferon, however, the duration of therapy will be significantly reduced versus current ...
... In genotype 1 patients - which account for the vast majority of the US hepatitis C population - the outlook is more complicated. Treatment with sofosbuvir will still require co-administration with ribavirin and interferon, however, the duration of therapy will be significantly reduced versus current ...
proper usage of drugs, chemicals and feed additives in food animals
... Reactions of an allergic or anaphylactic nature, sometimes fatal, have been known to occur in hypersensitive animals following the injection of oxytetracycline. Such adverse reactions can be characterized by signs such as restlessness, erection of hair, muscle trembling; swelling of eyelids, ears, m ...
... Reactions of an allergic or anaphylactic nature, sometimes fatal, have been known to occur in hypersensitive animals following the injection of oxytetracycline. Such adverse reactions can be characterized by signs such as restlessness, erection of hair, muscle trembling; swelling of eyelids, ears, m ...
Singulair - Merck.com
... Safety and effectiveness in pediatric patients younger than 12 months of age with asthma have not been established. SINGULAIR has been evaluated for safety in 175 pediatric patients 6 to 23 months of age. The safety profile of SINGULAIR in a 6-week, double-blind, placebo-controlled clinical study wa ...
... Safety and effectiveness in pediatric patients younger than 12 months of age with asthma have not been established. SINGULAIR has been evaluated for safety in 175 pediatric patients 6 to 23 months of age. The safety profile of SINGULAIR in a 6-week, double-blind, placebo-controlled clinical study wa ...
DESEANSIBILIZACION A ASA
... In a long-term study of 65 patients with ASA intolerance who underwent desensitization, there was a significant decrease in the number of infectious sinusitis and the use of prednisone with improvement in smell and symptoms of asthma and rhinitis. The need for sinus surgery decreased from one every ...
... In a long-term study of 65 patients with ASA intolerance who underwent desensitization, there was a significant decrease in the number of infectious sinusitis and the use of prednisone with improvement in smell and symptoms of asthma and rhinitis. The need for sinus surgery decreased from one every ...
Intersect ENT Announces Enrollment of First Patient In Phase III
... University in Chicago, Ill. and Pablo Stolovitzky, M.D., of ENT of Georgia in Atlanta, Ga., serve as coprincipal investigators of the study. Primary study endpoints include assessment of improvements through both patient-reported symptoms and objective endoscopic outcomes as determined by clinical i ...
... University in Chicago, Ill. and Pablo Stolovitzky, M.D., of ENT of Georgia in Atlanta, Ga., serve as coprincipal investigators of the study. Primary study endpoints include assessment of improvements through both patient-reported symptoms and objective endoscopic outcomes as determined by clinical i ...
Antihypertensive-Drugs.15.Mar.2011
... - drowsiness, weakness, orthostatic hypotension (first dose – bedtime administration) - for the nonselective agents, tachycardia - in patients with coronary disease, angina may be precipitated by the tachycardia - oral administration of any of these drugs can cause nausea, vomiting, diarrhoea - urin ...
... - drowsiness, weakness, orthostatic hypotension (first dose – bedtime administration) - for the nonselective agents, tachycardia - in patients with coronary disease, angina may be precipitated by the tachycardia - oral administration of any of these drugs can cause nausea, vomiting, diarrhoea - urin ...
IMMUNOTHERAPY:
... Patients may attempt to circumvent the vaccine by using larger doses of the drug, thereby increasing its adverse effects. Vaccine costly, possibly not a viable option for many abusers, especially since multiple injections are required to maintain antibody levels. Most effective on patients who h ...
... Patients may attempt to circumvent the vaccine by using larger doses of the drug, thereby increasing its adverse effects. Vaccine costly, possibly not a viable option for many abusers, especially since multiple injections are required to maintain antibody levels. Most effective on patients who h ...
Co-occurring addiction and mental disorders
... The present study investigated whether simultaneous treatment of social phobia and alcoholism, compared with treatment of alcoholism alone, improved alcohol use and social anxiety for clients with dual diagnoses of social anxiety disorder and alcohol dependence. METHODS: The design was a two-group, ...
... The present study investigated whether simultaneous treatment of social phobia and alcoholism, compared with treatment of alcoholism alone, improved alcohol use and social anxiety for clients with dual diagnoses of social anxiety disorder and alcohol dependence. METHODS: The design was a two-group, ...
Bilastine
Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma.Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine meets the current European Academy of Allergy and Clinical Immunology (EAACI) and Allergic Rhinitis and its Impact of Asthma (ARIA) criteria for medication used in the treatment of allergic rhinitis.Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.